SARI: Surveillance of antibiotic use and bacterial resistance in German intensive care units. Correlation between antibiotic use and the emergence of resistance;SARI: Surveillance der Antibiotikaanwendung und bakteriellen Resistenzentwicklung auf deutschen Intensivstationen: Zu den Zusammenhängen von Antibiotikaverbrauch und Resistenzsituation

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 47, Issue 4, 2004, Pages 345-351

  Meyer, E ^a   Jonas, D ^a   Schwab, F ^b   Gastmeier, P ^c   Ruden H ^b,d   Daschner, F D ^a,d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d Nationales Referenzzentrum für Surveillance nosokomialer Infektionen ^*  (Germany)

Author keywords

Antibiotic use; Intensive care units; Resistance rates; SARI; Surveillance

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; IMIPENEM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM; COMPARATIVE STUDY; DRUG EFFECT; DRUG UTILIZATION; GENETIC VARIABILITY; GENETICS; GERMANY; HEALTH SURVEY; HUMAN; INTENSIVE CARE UNIT; MULTIDRUG RESISTANCE; PSEUDOMONAS AERUGINOSA; QUALITY CONTROL; STANDARD; STAPHYLOCOCCUS AUREUS; THEORETICAL MODEL; TIME; WORLD HEALTH ORGANIZATION;

ANTI-BACTERIAL AGENTS; BACTERIA; BENCHMARKING; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG UTILIZATION; GERMANY; HUMANS; IMIPENEM; INTENSIVE CARE UNITS; MODELS, THEORETICAL; POPULATION SURVEILLANCE; PSEUDOMONAS AERUGINOSA; QUALITY CONTROL; STAPHYLOCOCCUS AUREUS; TIME FACTORS; VARIATION (GENETICS); WORLD HEALTH ORGANIZATION;

EID: 15944379928     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-004-0804-9     Document Type: Article

References (15)

1. Archibald L, Phillips L, Monnet D et al. (1997) Antimicrobial resistance in isolates from inpatients and outpatients in the United States: in-creasing importance of the intensive care unit. Clin Infect Dis 24: 211-215
2. Kresken M, D. Hafner FJ, Schmitz TA, Wichelhaus T (2003) Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Antibiotika in Deutschland und im mitteleuropäischen Raum. Antiinfectives Intellegence, Bonn
3. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 to June 2002 (2002) Am J Infect Control 30: 458-475
4. Fridkin SK, Steward CD, Edwards JR et al. (1999) Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Clin Infect Dis 29: 245-252
5. Monnet DL, Archibald LK, Phillips L et al. (1998) Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Infect Control Hosp Epidemiol 19: 388-394
6. Allegranzi B, Luzzati R, Luzzani A et al. (2002) Impact of antibiotic changes in empirical therapy on antimicrobial resistance in intensive care unit-acquired infections. J Hosp Infect 52: 136-140
7. Gerding DN, Larson TA, Hughes RA et al. (1991) Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother 35: 1284-1290
8. Monnet DL, Sorensen T.L. (1999) Interpreting the effectiveness of a national antibiotic policy and comparing antimicrobial use between countries. J Hosp Infect 43: 239-242
9. Meyer E, Jonas D, Schwab F et al. (2003) Design of a surveillance system of antibiotic use and bacterial resistance in German intensive Care units (SARI). Infection 31: 208-215
10. Tenover FC, Raney PM, Williams PP et al. (2003) Evaluation of the NCCLS extended-spectrum beta-Lactamase confirmation methods for Escherichia coli with isolates collected during project ICARE. J Clin Microbiol 41: 3142-3146
11. Natsch S, Conrad C, Hartmeier C., Schmid B. (1998) Use of amoxicillin-clavulanate and resistance in Escherichia coli over a 4-year period. Infect Control Hosp Epidemiol 19: 653-656
12. Seppala H, Klaukka T, Vuopio-Varkila J et al. (1997) The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 337: 441-446
13. Lepper PM, Grusa E, Reichl H et al. (2002) Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 46: 2920-2925
14. Weber SG, Gold HS, Hooper DC et al. (2003) Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 9: 1415-1422
15. Monnet DL, Lopez-Lozano JM, Campillos P et al. (2001) Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfer function models. Clin Microbiol Infect 7: 29-36